Market Research Logo

Ethiopia Pharmaceuticals and Healthcare Report Q4 2017

Ethiopia Pharmaceuticals and Healthcare Report Q4 2017

BMI View: Achieving pharmaceutical self-sufficiency will remain a challenging ambition for Ethiopia'slargely underdeveloped drug industry. Whilst progress has been made towards boosting the capacity of thedomestic industry, Ethiopia remains a long way from achieving sustainable medicine production. Greaterinterest from foreign investors and further government support will boost the capacity of Ethiopia'spharmaceutical landscape over the long term; however, opportunities for patented firms will be limitedgiven the weak purchasing power among large segments of the population.

Headline Expenditure Projections

Pharmaceuticals: ETB9.0bn (USD411mn) in 2016 to ETB9.7bn (USD417mn) in 2017; 7.9% growth inlocal currency terms and 1.3% in US dollar terms.

Healthcare: ETB59.1bn (USD2.7bn) in 2016 to ETB63.4 (USD2.7bn) in 2017; 7.4% growth in localcurrency terms and 0.9% in US dollar terms.

Innovative Risk/Reward Index

Ethiopia's pharmaceutical market will remain challenging for multinational drugmakers and offers limitedinvestment prospects for innovative firms, reflected in a score of 22.2 out of 100 in BMI's InnovativePharmaceuticals Risk/Reward Index. The high degree of poverty and continued poor healthcare access forrural populations will challenge medicine sales in the country. This is compounded by a lack of patentenforcement, market access barriers and elevated political risks.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Ethiopia 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ethiopia 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ethiopia 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ethiopia 2013-2021)
Industry Risk Reward Ratings
Sub-Saharan Africa Pharmaceuticals: Small Market Sizes Weaken Attractiveness To Innovative Drugmakers
Innovative Pharmaceuticals Risk/Reward Index - Ethiopia - Q4 2017
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Research-Based Industry
Demographic Forecast
Table: Population Headline Indicators (Ethiopia 1990-2025)
Table: Key Population Ratios (Ethiopia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Ethiopia 1990-2025)
Table: Population By Age Group (Ethiopia 1990-2025)
Table: Population By Age Group % (Ethiopia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report